GLP-1 receptor agonists such as the popular weight loss/diabetes therapies Mounjaro, developed by Eli Lilly (NYSE:LLY), and Ozempic, developed by Novo Nordisk (NVO), can reduce cancer risk, according ...

Four weeks after starting Mounjaro, Clare Meadowcroft was hospitalised for 10 days with acute pancreatitis and underwent ...

According to a report by the Financial Times, Morgan & Morgan, a law firm, revealed it had filed a case on behalf of a ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...

Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some ...

A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits ...

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to ...

A MUM thought her weight loss jabs were giving her trapped wind until she was racked by pains “worse than labour”, forcing ...

Influencer Tana Mongeau questioned if she had Ozempic vulva on TikTok, after reported side effect goes viral online.

Ozempic sales have risen five-fold after a 126 per cent rise in the price of the Mounjaro drug due to pressure from US ...

As Mounjaro doubles in price, we look at whether there’s another, cheaper way to suppress your appetite. By nutritionist ...

At six months, people taking Mounjaro shed 10.1% of their weight, while patients on Ozempic lost 5.9% Eli Lilly’s Mounjaro patients “were significantly more likely to achieve 5%, 10% and 15% ...